These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26724457)

  • 1. Self-adjuvanted hyaluronate--antigenic peptide conjugate for transdermal treatment of muscular dystrophy.
    Kong WH; Sung DK; Kim H; Yang JA; Ieronimakis N; Kim KS; Lee J; Kim DH; Yun SH; Hahn SK
    Biomaterials; 2016 Mar; 81():93-103. PubMed ID: 26724457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional improvement of dystrophic muscle by myostatin blockade.
    Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
    Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
    Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
    Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myostatin propeptide-mediated amelioration of dystrophic pathophysiology.
    Bogdanovich S; Perkins KJ; Krag TO; Whittemore LA; Khurana TS
    FASEB J; 2005 Apr; 19(6):543-9. PubMed ID: 15791004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategies for muscular dystrophy by myostatin inhibition].
    Sunada Y
    Rinsho Shinkeigaku; 2006 Nov; 46(11):942-4. PubMed ID: 17432227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E; Pennington C; Isales CM; Hamrick MW
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronate-Epidermal Growth Factor Conjugate for Skin Wound Healing and Regeneration.
    Kim H; Kong WH; Seong KY; Sung DK; Jeong H; Kim JK; Yang SY; Hahn SK
    Biomacromolecules; 2016 Nov; 17(11):3694-3705. PubMed ID: 27775884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of α7 nicotinic acetylcholine receptor (nAChRα7) inhibits muscular degeneration in mdx dystrophic mice.
    Leite PE; Gandía L; de Pascual R; Nanclares C; Colmena I; Santos WC; Lagrota-Candido J; Quirico-Santos T
    Brain Res; 2014 Jul; 1573():27-36. PubMed ID: 24833065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLPG0492, a novel selective androgen receptor modulator, improves muscle performance in the exercised-mdx mouse model of muscular dystrophy.
    Cozzoli A; Capogrosso RF; Sblendorio VT; Dinardo MM; Jagerschmidt C; Namour F; Camerino GM; De Luca A
    Pharmacol Res; 2013 Jun; 72():9-24. PubMed ID: 23523664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of hyaluronic acid -- human growth hormone conjugate.
    Yang JA; Kim ES; Kwon JH; Kim H; Shin JH; Yun SH; Choi KY; Hahn SK
    Biomaterials; 2012 Sep; 33(25):5947-54. PubMed ID: 22632765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
    Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
    Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronate - parathyroid hormone peptide conjugate for transdermal treatment of osteoporosis.
    Cho M; Han S; Kim H; Kim KS; Hahn SK
    J Biomater Sci Polym Ed; 2018; 29(7-9):793-804. PubMed ID: 29115187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of myostatin and follistatin in Mdx mice, an animal model for muscular dystrophy.
    Abe S; Soejima M; Iwanuma O; Saka H; Matsunaga S; Sakiyama K; Ide Y
    Zoolog Sci; 2009 May; 26(5):315-20. PubMed ID: 19715499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.
    Wagner KR; McPherron AC; Winik N; Lee SJ
    Ann Neurol; 2002 Dec; 52(6):832-6. PubMed ID: 12447939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Therapy With Omega-3 Ameliorates Myonecrosis and Benefits Skeletal Muscle Regeneration in Mdx Mice.
    Apolinário LM; De Carvalho SC; Santo Neto H; Marques MJ
    Anat Rec (Hoboken); 2015 Sep; 298(9):1589-96. PubMed ID: 26011009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype of dystrophinopathy in old mdx mice.
    Lefaucheur JP; Pastoret C; Sebille A
    Anat Rec; 1995 May; 242(1):70-6. PubMed ID: 7604983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy.
    Vianello S; Yu H; Voisin V; Haddad H; He X; Foutz AS; Sebrié C; Gillet B; Roulot M; Fougerousse F; Perronnet C; Vaillend C; Matecki S; Escolar D; Bossi L; Israël M; de la Porte S
    FASEB J; 2013 Jun; 27(6):2256-69. PubMed ID: 23430975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the minimum peptide from mouse myostatin prodomain for human myostatin inhibition.
    Takayama K; Noguchi Y; Aoki S; Takayama S; Yoshida M; Asari T; Yakushiji F; Nishimatsu S; Ohsawa Y; Itoh F; Negishi Y; Sunada Y; Hayashi Y
    J Med Chem; 2015 Feb; 58(3):1544-9. PubMed ID: 25569186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of myostatin reverses muscle fibrosis through apoptosis.
    Bo Li Z; Zhang J; Wagner KR
    J Cell Sci; 2012 Sep; 125(Pt 17):3957-65. PubMed ID: 22685331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.